Form 4: ANI Pharmaceuticals Executive Marken James G. Reports Stock Transaction
SEC Form 4 Filing
SVP of Operations and Product Development at ANI Pharmaceuticals, James G. Marken, reports disposition of shares for tax purposes following vesting of restricted stock.
Summary
- On March 23, 2024, James G. Marken, SVP of Operations and Product Development at ANI Pharmaceuticals, reported a transaction involving common stock.
- 3,653 shares were disposed of to cover tax obligations related to the vesting of 8,010 shares of restricted stock.
- The transaction was exempt under Rule 16(b)-3.
- The price per share for the transaction was $69.58.
- Following the transaction, Marken directly owns 118,805 shares of ANI Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: This is a neutral filing related to a routine stock transaction for tax purposes. It doesn't indicate any positive or negative sentiment towards the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax withholding procedure related to the vesting of restricted stock, which is a common form of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/23/2024 | Date of stock transaction (disposal of shares). |
| 03/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.